Do reassessments reduce the uncertainty of decision making? Reviewing reimbursement reports and economic evaluations of three expensive drugs over time
Year of publication: |
2013
|
---|---|
Authors: | Sandmann, Frank G. ; Franken, Margreet G. ; Steenhoek, Adri ; Koopmanschap, Marc A. |
Published in: |
Health Policy. - Elsevier, ISSN 0168-8510. - Vol. 112.2013, 3, p. 285-296
|
Publisher: |
Elsevier |
Subject: | Drug reimbursement | Systematic review | Evidence development | Imatinib | Pegfilgrastim | Adalimumab |
-
Calhoun, Elizabeth A., (2005)
-
Pharmacoeconomics of the Myeloid Growth Factors: A Critical and Systematic Review
Hirsch, Bradford R., (2012)
-
Darkow, Theodore, (2007)
- More ...
-
Gaultney, Jennifer G., (2015)
-
Productivity and quality of Dutch hospitals during system reform
Ineveld, Martin van, (2016)
-
Indirect costs of disease; an international comparison
van Roijen, Leona, (1995)
- More ...